跳至主要内容
临床试验/NCT00993213
NCT00993213已完成不适用

Mechanisms Defending Fat Mass in Humans After Lipectomy

University of Colorado, Denver2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2004年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
2
主要终点
Changes in body composition.

研究概览

简要总结

Liposuction surgery is common, yet animal and limited human data suggest that fat returns when removed. This study was designed as a 1-year randomized-controlled trial of suction lipectomy versus no intervention to determine if adipose tissue is defended, and if so to determine the anatomic pattern of redistribution.

详细描述

Specific Aims:

  1. To determine if suction lipectomy fails to modify regional and/or total body fat over three years.
  2. To determine if the expression of candidate genes predicts and/or relates to subcutaneous adipose tissue growth or depletion in subcutaneous adipose tissue after suction lipectomy.
  3. To examine adipose tissue before and after suction lipectomy to uncover novel genes where expression predicts and/or relates to subcutaneous adipose tissue growth or depletion after subcutaneous suction lipectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Eligible premenopausal women between the ages of 18-50 years;
  • BMI of 22-27 kg/m2 at the subjects maximum body weight;
  • Weight stable for at least 3 months (defined as a <5-7% change from the maximum weight over 3-6 months);
  • Non-smokers.

排除标准

  • Any history of glucose intolerance, dyslipidemia, liver, kidney and cardiac disease, hypertension, cancer or any other chronic debilitating disorder that might have interfered with a 'normal' lifestyle, e.g. nutrition, physical activity;
  • Thyroid hormone replacement with abnormal thyroid stimulating hormone (TSH) results;
  • Use of oral contraceptives if the subject did/could not remain on therapy throughout study participation.
  • Reduced-obese, defined as a history of:
  • obesity and weight loss >10% of maximum body weight, or
  • liposuction or gastric bypass surgery;
  • Evidence of body dysmorphic disorder;
  • Taking sex steroids, glucocorticoids, or medications affecting carbohydrate and lipid metabolism;
  • Hematocrit, hemoglobin, white blood cell count (WBC), platelet count, liver or renal function tests out of the normal range;
  • Fasting plasma glucose >110 mg/dL;
  • Triglycerides >200 mg/dL;
  • High density lipoprotein (HDL) cholesterol <35 mg/dL;
  • Low density lipoprotein (LDL) cholesterol >160 mg/dL;
  • Proteinuria;
  • Blood pressure >140/90 mm/Hg;
  • Electrocardiogram abnormalities;
  • History of claustrophobia;
  • Placement of metal implants*
  • History of internal metal fragments*
  • *Were evaluated by the radiologist prior to study determination*

结局指标

主要结局

Changes in body composition.

时间窗: Baseline, 6wks, 6mos, 1-year

Changes in body composition as measured by Dual X-ray Absorptiometry (DXA).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验